Influence of Adipokines on Metabolic Dysfunction and Aging

Area of Science:

• Metabolic disorders and aging research.
• Endocrinology and molecular biology.
• Obesity and longevity science.

Background:

• Global obesity rates are alarmingly high, projected to exceed 50% by 2035, increasing metabolic syndrome risks.
• Adipose tissue dysfunction in obesity is linked to hypertension, hyperglycemia, and dyslipidemia.
• Visceral fat accumulation is a marker of aging and associated with increased mortality.

Purpose of the Study:

• To review the role of adipokines in obesity and metabolic disorders.
• To explore adipokines as potential targets for longevity interventions.
• To understand the connection between adipose tissue dysfunction and metabolic health.

Main Methods:

• Literature review of scientific articles on adipokines, obesity, and metabolic health.
• Analysis of the regulatory functions of adipokines in appetite, satiety, and metabolism.
• Exploration of existing research on adipokines and their link to aging and lifespan.

Main Results:

• Adipokines are crucial regulators of appetite, satiety, adiposity, and metabolic balance.
• Dysfunctional adipose tissue in obesity contributes to metabolic abnormalities.
• Certain adipokines show promise in alleviating metabolic diseases and extending health span.

Conclusions:

• Adipokines play a significant role in the development of obesity and related metabolic disorders.
• Targeting specific adipokines may offer novel therapeutic strategies for metabolic diseases.
• Adipokines represent potential candidates for interventions aimed at promoting longevity and health span.